Team SFB 829

SFB 829 group leaders 

Thomas Krieg, Raimund Wagener, Roswitha Nischt, Frank Zaucke, Mats Paulsson, Beate Eckes, Sabine Eming, Sandra Iden, Gerhard Sengle, Manuel Koch, Sara Wickström, Mario Fabri, Matthias Hammerschmidt, Catherin Niemann and Carien Niessen (from the left to the right)

Eight members build up the Executive Board of the SFB 829: The speaker Prof. Carien Niessen, vice-speaker Prof. Thomas Krieg and six other principle investigator, Prof. Manolis Pasparakis, Prof. Mats Paulsson, Dr. Sara Wickström, Dr. Björn Schumacher, Prof. Dr. Sabine Eming and Dr. Sandra Iden.

The SFB contains 20 Research Groups (A1-B15) with 26 principle investigators and four Central Service Projects, Z1, Z2, Z3 and Z4. Several new university recruitment have strengthened this SFB by providing novel expertise. New structures have been implemented within participating departments with the aim to provide a bridge function between basic science and clinical medicine.

The speaker Prof. Carien Niessen, vice-speaker Prof. Thomas Krieg, managing coordinator Dr. Susanne Vorhagen and our student assistant Rachel Pikelhaizen from the Central Administration.

13 Research Groups that are interested in the SFB 829 to align their research interests with skin related topics are associated to the SFB 829.

Seven international experts from USA, Netherlands, UK, Switzerland and Germany are members of our External Advisory Board, ensuring an outstanding consultancy and supervision.

Working together with nine nationwide and internationally known Institutions, the SFB is embedded into an excellent research environment.

  • Upcoming Events

    1. Postponed: SFB 829 International Symposium

      November 8 - November 10
  • News

© 2017 SFB 829

Durch die weitere Nutzung der Seite stimmst du der Verwendung von Cookies zu. Weitere Informationen

Die Cookie-Einstellungen auf dieser Website sind auf "Cookies zulassen" eingestellt, um das beste Surferlebnis zu ermöglichen. Wenn du diese Website ohne Änderung der Cookie-Einstellungen verwendest oder auf "Akzeptieren" klickst, erklärst du sich damit einverstanden.